CT-004

N/A

Report date: 2023/08/17 17:50:55

Base Information

Drug NameCT-004
Drug Alias NameCT-004
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor replacements
TargetsUpdating
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A